In this study, we analyzed publicly available NB patient data sets and revealed that EIF4EBP1 is overexpressed in NB compared to normal tissues, is significantly co-expressed with MYCN, and is elevated in high-risk relatively to low-risk tumor groups. The gene discussed is MYCN; the disease is neuroblastoma.